The effect of stress ball use on stress, sleep quality, and comfort in individuals receiving hemodialysis: a randomized controlled trial Authors: Ayse Kacaroglu Vicdan, Dilek Gibyeli Genek Published: 2026 ABSTRACT AbstractBackgroundHemodialysis often leads to various physiological, psychological, and social challenges for individuals receiving this treatment. This study was conducted to determine the effects of stress ball use on stress, sleep quality, and comfort levels in individuals receiving hemodialysis.MethodsThis single-blind randomized controlled trial was conducted with 57 patients (28 experimental, 29 control) receiving treatment at a hemodialysis unit in western Türkiye between February and April 2024. Participants were selected using a simple random sampling method from the eligible patient population. The stress ball intervention was administered three times weekly during hemodialysis sessions for 15 min each session, totaling 12 sessions. The control group received standard hemodialysis treatment and nursing care. The study data were collected using a Patient Assessment Form, the Perceived Stress Scale, Pittsburgh Sleep Quality Index, and Hemodialysis Comfort Scale Version II.ResultsThere was no significant difference in pre-test PSS scores between the experimental and control groups (p > 0.05), whereas post-test scores were significantly lower in the experimental group (p < 0.05). For the PSQI, pre-test scores differed significantly between the groups (p < 0.05), but no significant difference was found in post-test scores (p > 0.05). Within-group analysis showed a significant decrease in the experimental group (p < 0.05), while no change was observed in the control group (p > 0.05). ANCOVA confirmed that adjusted post-test PSQI scores were lower in the experimental group (p < 0.05), indicating improved sleep quality. No statistically significant differences were found between the groups in HDCS-II total or subscale scores at either measurement point (p > 0.05).ConslusionThis study shows that the use of stress balls reduces the perceived stress levels of individuals receiving hemodialysis treatment while enhancing their sleep quality and comfort levels.Trial registrationClinicalTrials.gov (NCT06835998). The date of registration is 2025-02-19 (Retrospectively registered).Supplementary InformationThe online version contains supplementary material available at 10.1186/s12906-026-05429-9.Keywords: Stress ball, Stress, Sleep quality, Comfort, Hemodialysis Introduction Chronic kidney disease (CKD) is a progressive and irreversible chronic illness. Due to its rising prevalence and high treatment costs, CKD represents a significant public health issue around the world [1, 2]. Hemodialysis is the most frequently preferred renal replacement therapy for CKD treatment. The hemodialysis process often leads to numerous physiological, psychological, and social challenges for patients. Individuals receiving hemodialysis commonly experience constipation, nausea, vomiting, loss of appetite, diarrhea, dizziness, muscle cramps, leg swelling, restless leg syndrome, coughing, fistula complications, dry mouth, skin dryness, itching, chest and back pain, restlessness, susceptibility to infections, anemia, bleeding, irritability, sexual dysfunction, concentration difficulties, depression, stress, sleep disorders, and reduced comfort [3–5]. Stress is one of the primary challenges for inividuals receiving hemodialysis, as they endure various physical and psychological stressors. The hemodialysis treatment process significantly limits patients’ daily activities, making it a major source of stress [6, 7]. Additionally, dependency on machines and healthcare personnel, medication and dietary restrictions, job loss, disrupted social relationships, and physical ailments further contribute to their stress levels. Insufficient psychological and social support systems also hinder patients’ ability to cope with stress. With increased stress levels, patients experience reduced quality of life, which complicates their adaptation to the treatment process [7–10]. Another prevalent issue for individuals receiving hemodialysis involves sleep-related problems. The prevalence of sleep disturbances among individuals diagnosed with CKD is reported to be higher than in the general population, ranging from 40% to 80% [11, 12]. These patients commonly experience challenges such as waking up readily, poor sleep quality, insomnia, daytime sleepiness, and sleep apnea syndrome [12, 13]. Deteriorated sleep quality has become a significant factor impairing the quality of life for individuals receiving hemodialysis. Studies indicate that poor sleep quality in these patients can lead to cognitive impairment, decreased social performance, reduced interpersonal communication, fatigue, and various physical, behavioral, and psychological disorders [13–15]. Given that sleep is a fundamental need, evaluating sleep patterns is essential in nursing care. Nurses should, therefore, assess sleep patterns, identify sleep issues and their causes, and plan, implement, and evaluate nursing interventions aimed at resolving these issues in individuals receiving hemodialysis [16, 17]. Issues associated with hemodialysis treatment significantly impact patient comfort. Comfort is a fundamental human need that must be met for everyone. There are various factors affecting the comfort of individuals receiving hemodialysis [18]. These include the necessity of regular visits to dialysis centers, movement restrictions during sessions, reduced personal independence due to treatment, and symptoms like fatigue, itching, insomnia, and diminished social interactions, all of which reduce daily comfort levels [19, 20]. In nursing care, ensuring patient comfort is deemed an essential factor of quality care. Therefore, nurses must identify the comfort needs of each patient, plan and implement nursing interventions to address these needs, and assess the patient’s comfort level [21, 22]. Considering the challenges faced by individuals receiving hemodialysis treatment, there is a growing interest in and need for evidence-based, non-pharmacological methods to alleviate these issues. Commonly used non-pharmacological methods for reducing the problems experienced by hemodialysis patients include acupressure [10], meditation [23], massage [24], yoga [25], music therapy [9], reflexology [26], reiki [27], aromatherapy [28], and the use of stress balls as a distraction technique [29–31]. As a distraction technique, the stress ball also stimulates numerous nerves and muscles in the wrist and hand, which are directly connected to the brain, by applying pressure around and within these areas. This process regulates the nervous system’s function, reduces the release of stress hormones, and promotes relaxation [29, 30] Studies indicate that stress ball use increases patient satisfaction, reduces anxiety and stress, and positively influences vital signs [29–31]. However, no study has yet evaluated the combined effects of stress ball use on stress, sleep quality, and comfort levels. Therefore, the findings of this study are expected to guide nurses by determining how stress ball use impacts stress, sleep quality, and comfort in individuals receiving hemodialysis, thereby providing evidence for non-pharmacological methods that nurses can apply to their patients. This study was conducted to determine the impact of stress ball use on stress, sleep quality, and comfort levels in individuals receiving hemodialysis. It was hypothesized that the use of stress balls would be effective in reducing stress levels and improving sleep quality and comfort levels in individuals receiving hemodialysis. Methods Study design and setting This single-blind randomized controlled trial was conducted between February 19, 2024, and April 19, 2024, at the hemodialysis unit of a training and research hospital in western Türkiye. The study population comprised 90 patients receiving individuals receiving hemodialysis at the study site during the data collection period. Participants were selected using a simple random sampling method from the eligible patient population. A priori power analysis was conducted using G*Power version 3.1.9.7 to determine the required sample size for detecting differences between groups. Based on a type I error rate of 0.05, a type II error rate of 0.20 (power = 80%), and an effect size of 0.80, the minimum required sample size was calculated as 26 participants per group (N = 52). To account for potential attrition, the sample size was increased by 15%, resulting in a planned enrollment of 30 participants per group (N = 60). During the study, a total attrition rate of 5.0% (n = 3) was observed, with 6.6% (n = 2) in the experimental group and 3.3% (n = 1) in the control group. In the experimental group, one participant experienced a brain hemorrhage and another sustained a broken arm, preventing their continuation in the study. In the control group, one participant withdrew due to a broken arm. These withdrawals were unrelated to the intervention. Given the low attrition rate, it was determined that the assumption of randomness was not compromised. Although the intention-to-treat (ITT) approach is considered a cautious strategy in cases of low attrition, it has been reported to increase the risk of type II errors and potentially reduce the observed positive effect of the intervention [32]. Therefore, to more accurately reflect the true effect of the intervention, a per- protocol analysis method was preferred. The study was completed with a total of 57 individuals receiving hemodialysis, comprising 28 in the experimental group and 29 in the control group (Fig. 1). CONSORT flow diagram Eligibility criteria The inclusion criteria for the study were defined as follows: individuals had to be aged 18 years and older, receiving hemodialysis treatment for at least six months, attending hemodialysis sessions three times a week, having no diagnosed psychiatric illness, and having no condition that would prevent the use of a stress ball. Eligible individuals were informed about the study by the researchers, and those who voluntarily agreed to participate and provided written informed consent were included in the study. Individuals who had been receiving hemodialysis treatment for less than six months were excluded from the study to ensure a more stable sample, as they might still have been adapting to the treatment process. In addition, previous studies in the literature have also used a six-month duration as an inclusion criterion [30]. The exclusion criteria were as follows: individuals receiving hemodialysis for less than six months, patients attending hemodialysis sessions twice a week, presence of a diagnosed psychiatric disorder, and individuals with health problems that prevented them from using a stress ball. Randomization and blinding In the initial phase of the study, 60 patients meeting the inclusion criteria completed the Patient Assessment Form. A simple random sampling method and simple randomization were used for participant selection. The sample was assigned to groups homogeneously with the aid of a table of random numbers, ensuring allocation concealment. Stratified block randomization by sex was employed to assign participants to the experimental and control groups, and group homogeneity was examined particularly with respect to age and duration of hemodialysis. The constructed blocks were repeated 15 times for each group (2 × 2 × 15) to allocate a total of 60 participants. To eliminate the potential for bias in randomization, the procedure was carried out by an independent researcher who was not involved in the study. A flowchart was prepared using the CONSORT diagram (Fig. 1). Although participants in the experimental group used the stress ball during hemodialysis sessions, they were not informed about the existence of other groups or their group assignments, ensuring partial participant blinding. In addition, data collector, and statistical analysts were blinded to group assignments to minimize potential bias. Study variables Dependent variables Stress level, sleep quality, and comfort level. Independent variable The application of the stress ball. Control variables Gender, age, and duration of hemodialysis. Outcome measures The primary outcome measures were stress levels, sleep quality, and comfort levels in individuals receiving hemodialysis. The study data were collected using a Patient Assessment Form, the Perceived Stress Scale, Pittsburgh Sleep Quality Index, and Hemodialysis Comfort Scale Version II. Patient assessment form This form, which included the socio-demographic and health characteristics of individuals receiving hemodialysis, was prepared by the researchers based on a review of the literature [30, 31]. The form consists of 12 questions related to the participants’ socio-demographic and health characteristics, including age, gender, occupation, education, marital status, social security, living arrangements, income status, support received, time since initial diagnosis, duration of treatment, and the presence of additional chronic illnesses. Perceived stress scale (PSS) The scale used to measure patients’ perceived stress levels was developed by Cohen, Kamarck, and Mermelstein in 1983 [33] and adapted into Turkish by Eskin et al. [34]. It consists of 14 items, with each item evaluated on a 5-point Likert scale ranging from “Never (0)” to “Very Often (4).” The obtainable total score from the scale ranges from 0 to 56, with higher scores indicating a greater perception of stress. The Cronbach’s alpha coefficient for the scale is 0.84 [34]. In the present study, the Cronbach’s alpha coefficient was 0.80 in the pre-test and 0.90 in the post-test. Pittsburgh sleep quality index (PSQI) PSQI was developed by Buysse et al. (1989) to assess the quality of sleep over a one-month period [35]. Its Turkish validity and reliability study was conducted by Ağargün et al. (1996) [36]. It consists of 18 questions, providing information on seven components: sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction. Each component is scored on a scale of 0 to 3. The sum of the scores from these seven components yields the total PSQI score, which ranges from 0 to 21. Individuals with a total score of 5 or lower are classified as having ‘good” sleep quality, while those with a score above 5 are classified as having “poor” sleep quality. The Cronbach’s alpha coefficient for the scale is 0.80 [36]. In the current study, the Cronbach’s alpha coefficients were 0.85 in the pre-test and 0.86 in the post-test. Hemodialysis comfort scale version II (HDCS-II) The comfort level of individuals receiving hemodialysis is measured using a scale developed by Koşar Şahin and Çınar Pakyüz in 2021 [18]. This scale consists of 26 items and six subscales, utilizing a five-point Likert type format. Non-reversed items (19, 20, 22, 25, 26) are scored from 1 to 5, while reversed items (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 21, 23, 24) are scored from 5 to 1. The subscales and their score ranges are as follows: Physical relief includes items 5, 6, 7, and 8 (4–20 points); physical ease consists of items 1, 2, 3, and 4 (4–20 points); psychospiritual ease includes items 18, 19, 20, 21, 22, 23, 24, 25, and 26 (9–45 points); sociocultural relaxation covers items 9, 10, and 11 (3–15 points); psychospiritual transcendence includes items 14, 15, 16, and 17 (4–20 points); and environmental transcendence comprises items 12 and 13 (2–10 points). The total score obtained from the scale ranges from 26 to 130, with higher scores indicating greater comfort levels. The Cronbach’s alpha coefficient for the scale is 0.79 [18]. In this study, the Cronbach’s alpha coefficients were 0.81 in the pre-test and 0.80 in the post-test. Implementation Experimental group After obtaining verbal and written consent from patients in the experimental group, pre-test data were collected by having them complete PSS, PSQI and HDCS-II during their hemodialysis session. Subsequently, the stress ball intervention was initiated. Before starting, the researcher provided instructions and demonstrations on how to use the stress ball, allowing then the patients to practice. The stress ball intervention was administered during the second hour of the hemodialysis session when patients were most comfortable. Patients were instructed to squeeze the stress ball once, counting internally as “1-2-3” with each squeeze. The stress ball intervention was administered three times weekly during hemodialysis sessions for 15 min each session, totaling 12 sessions for a period of four weeks. The 15-minute duration and three-times-weekly frequency were determined based on previous studies conducted in hemodialysis populations, which reported beneficial effects of similar intervention dosages [30]. Throughout the intervention, patients were observed by the same researcher. To prevent variations in stress ball use that could potentially influence study outcomes, patients were asked to not to use the stress ball outside of hemodialysis treatment. Following each application, the researcher collected the stress balls and redistributed them at the beginning of the next session. To prevent the mixing of stress balls, each was placed in a labeled bag designated for individual patients and stored by the researcher. The stress balls were obtained in a quantity specific to each patient and were not collected back after the study concluded. The stress balls used in the study were round, colorful, having medium firmness, and made from high-quality silicone. After completing the stress ball intervention (12 sessions, four weeks) with the experimental group PSS, PSQI and HDCS-II were administered again to collect post-test data. Data collection took place in the hemodialysis unit during the dialysis through face-to-face interactions, with each session lasting approximately 15 min on average. Pre - test and post - test data of the study were collected by the same researcher. To prevent information sharing between groups, participants were instructed not to discuss any details about the study or the intervention with other patients, and these reminders were repeated before each hemodialysis session. Furthermore, to minimize interaction between the groups, patients in the intervention group were assigned to hemodialysis machines located at a distance from those used by the control group. Control group After obtaining verbal and written consent from the patients in the control group, pre-test data were collected using PSS, PSQI and HDCS-II during their hemodialysis session. Without any additional interventions, the control group received only the standard hemodialysis treatment protocol and nursing care. Four weeks later, the control group again completed PSS, PSQI and HDCS-II to collect post-test data. The data were collected face-to-face in the hemodialysis unit during the hemodialysis session, with an average time of 15 min. Pre - test and post - test data of the study were collected by the same researcher. At the end of the study, stress balls were also provided to participants in the control group to fulfill the principle of equity. Ethical considerations To conduct the study, ethical approval was obtained from the institution’s Scientific Research and Publication Ethics Committee (Date: February 13, 2024; Decision No: 240010/29), along with institutional permission from the hospital where the research was conducted. In addition, written informed consent was obtained from the patients after they were informed about the study’s purpose. Permission to use the scales was acquired via email from the scale developers. The trial was retrospectively registered on the ClinicalTrials.gov website (Identifier: NCT06835998) on February 19, 2025, due to administrative delays; all study methods, inclusion criteria, interventions, and outcome measures were determined prior to patient enrollment and remained unchanged throughout the study period. This research was conducted in accordance with the principles of research and publication ethics of the World Medical Association Declaration of Helsinki, adhering to the Ethical Principles for Medical Research Involving Human Subjects 2013/64 general assembly decisions. Data analysis The study data were analyzed using Statistical Package for Social Sciences (SPSS) 26. The Kolmogorov-Smirnov test was employed to assess data distribution, leading to the decision to use parametric tests. Categorical variables were expressed as numbers and percentages, while numeric variables were expressed as means and standard deviations. Chi-square and independent samples t-tests were used to examine differences between groups, while paired samples t-tests and Cohen’s d value was used for effect width value. ANCOVA test was performed to eliminate the effect of initial differences in PSQI pre-test scores. Cronbach’s alpha coefficient was calculated for the reliability of the scales. Statistical significance was set at p<0.05. Results The average age of patients in the experimental group was 60.32 ± 12.84 years, with 65.5% being male, 78.6% having completed primary education, 46.4% retired, 64.3% married, 82.1% having social security, 75% having a moderate economic status, 57.1% receiving support, and 60.7% living with their spouse. The duration of hemodialysis treatment for these patients was 4.28 ± 3.18 years (Min = 1 year, Max = 13 years), with 64.3% having additional chronic diseases. In the control group, the average age of individuals was 60.10 ± 13.23 years, with 64.7% being male, 55.2% having completed primary education, 55.2% retired, 55.2% married, 86.2% having social security, 82.2% having a moderate economic status, 65.5% receiving support, and 48.3% living with their spouse. The duration of hemodialysis treatment for these patients was 4.05 ± 2.57 years (Min = 6 months, Max = 11 years), with 65.5% having additional chronic diseases. There were no significant differences between the experimental and control groups regarding socio-demographic and health characteristics (p > 0.05) (Table 1). Table 1Comparison of the socio-demographic and disease characteristics of patients in the experimental and control groups (n = 57)VariablesExperimental Group (n = 28)Control Group (n = 29) n % n %Χ2 p Age group 22–55 years1035.71034.50.0090.922 56–84 years1864.31965.5Mean age (years)60.32 ± 12.8460.10 ± 13.23Gender Female1035.71034.50.0090.922 Male1864.31965.5Educational level Primary school2278.61655.24.6420.098 Secondary school414.3517.2 University27.1827.6Occupation Housewife932.1620.70.9700.616 Working621.4724.1 Retired1346.41655.2Marital status Married1864.31655.20.4920.483 Single1035.71344.8Social security status Yes2382.12586.20.1770.730 None517.9413.8Economic status Middle2175.02482.80.5160.473 Bad725.0517.2Support status Yes1657.11965.50.4220.516 No1242.91034.5Person(s) lived with Alone621.4827.60.8920.640 With his/him wife1760.71448.3 Mother/father517.9724.1Hemodialysis diagnosis time Immediately1035.71137.90.1440.930 6 month-4 years1139.31034.5 5 years and above725.0827.6Hemodialysis treatment time 6 months-2 years1139.3827.61.6100.447 3 years-5 years932.11448.3 6 years and above828.6724.1Hemodialysis treatment duration (years)4.28 ± 3.184.05 ± 2.57Additional chronic disease Yes1864.31965.50.0090.922 None1035.71034.5Abbreviations: Χ2 Chi squareSignificant at the level of p < 0.05 Comparison of the socio-demographic and disease characteristics of patients in the experimental and control groups (n = 57) Abbreviations: Χ2 Chi square Significant at the level of p < 0.05 Considering the mean PSS scores of the participants, there was no significant difference in the total pre-test score averages between the groups (p > 0.05). However, a significant difference was observed in the post-test score averages (p < 0.05). Within-group analysis of the PSS score averages revealed that the perceived stress level of patients in the experimental group significantly decreased (pre-test: 29.64 ± 9.28; post - test: 19.86 ± 10.84) (p < 0.05). Conversely, the perceived stress level of patients in the control group significantly increased (pre - test: 32.17 ± 7.07; post - test: 36.17 ± 7.54) (p < 0.05) (Table 2). Table 2Comparison of PSS score averages of patients in the experimental and control groups (n = 57)PSSExperimental Group (n = 28) Mean ± SDControl Group (n = 29) Mean ± SDTest valuea p Cohen’s dPre - test29.64 ± 9.2832.17 ± 7.07-1.1600.2510.30Post - test19.86 ± 10.8436.17 ± 7.54-6.617 < 0.001 1.75 Test value b 7.620 -4.118 p < 0.001 < 0.001 Cohen’s d -1.600.79Abbreviations: PSS Perceived Stress Scale, SD Standart Deviationa Independent sample t test, b Dependent sample t testBold values indicate statistically significant results p < 0.05 Comparison of PSS score averages of patients in the experimental and control groups (n = 57) Abbreviations: PSS Perceived Stress Scale, SD Standart Deviation a Independent sample t test, b Dependent sample t test Bold values indicate statistically significant results p < 0.05 There was a significant difference in the pre-test PSQI score averages between the experimental and control groups (p < 0.05), while there was no significant difference in the post-test PSQI score averages (p > 0.05). Within-group analysis of the PSQI score averages showed that the average PSQI score of the experimental group significantly decreased (p < 0.05), whereas there was no significant change in the average PSQI score of the control group (p > 0.05) (Table 3). To eliminate the effect of baseline differences in pre-test scores, an ANCOVA was conducted. The results revealed a statistically significant difference between the groups in post-test PSQI scores adjusted for pre-test measurements (F = 11.509, p = 0.001). Examination of the adjusted mean values showed that the control group’s post-test PSQI score (7.32) was higher than that of the experimental group (4.63). The analysis indicated a substantial effect size (partial eta squared = 0.176) and high statistical power (0.915). Table 3Comparison of PUKI score averages of patients in the experimental and control groups (n = 57)PSQIExperimental Group (n = 28) Mean ± SDControl Group (n = 29) Mean ± SDTest valuea p Cohen’s dPre - test9.11 ± 5.316.62 ± 3.70-2.044 0 0.045 -0.54Post - test5.36 ± 4.086.62 ± 3.67-1.2300.2240 0.32 Test value b 4.681 0.000 p p < 0.001 1.000 Cohen’s d -0.81 0.00 Abbreviations: PSQI Pittsburgh Sleep Quality Index, SD Standart Deviationa Independent sample t test, b Dependent sample t testBold values indicate statistically significant results p < 0.05 Comparison of PUKI score averages of patients in the experimental and control groups (n = 57) Abbreviations: PSQI Pittsburgh Sleep Quality Index, SD Standart Deviation a Independent sample t test, b Dependent sample t test Bold values indicate statistically significant results p < 0.05 There was no significant difference between the experimental and control groups in the pre-test and post-test HDCS- II total and subscale mean scores (p > 0.05). However, within-group analysis of pre-test and post-test mean scores showed a significant increase in the experimental group’s HDCS- II total score and in the mean scores of the physical relaxation, environmental enhancement, and sociocultural relaxation subscales. In the control group, only the sociocultural relaxation subscale mean score demonstrated a statistically significant increase (p < 0.05) (Table 4). Table 4Comparison of HDSC II total and subscale score averages of experimental and control groups (n = 57)HDSC IIExperimental Group (n = 28) Mean ± SDControl Group (n = 29) Mean ± SDTest valuea p Cohen’s dPhysical relief (Pre - Test)12.89 ± 3.8213.86 ± 3.83-0.9560.3430.25Physical relief (Post - Test)13.93 ± 4.0413.17 ± 3.96-1.1740.2460.31Test valueb /p-1.479/0.151-1.637/0.113 Cohen’s d 0.280.38Physical ease (Pre - test)16.57 ± 2.6416.55 ± 2.370.0300.976-0.00Physical ease (post - test)18.18 ± 1.8916.76 ± 2.860.6520.517-0.17Test valueb /p -3.306/0.003* -1.891/0.069 Cohen’s d 0.550.39Psychospiritual ease (Pre - Test)28.04 ± 8.6531.21 ± 7.93-1.4440.1540.38Psychospiritual ease (Post - Test)29.07 ± 8.7231.17 ± 7.65-0.9680.3370.25Test valueb /p-1.285/0.2100.039/0.969 Cohen’s d 0.24-0.00Psychospiritual transcendence (Pre - Test)14.43 ± 4.4216.00 ± 4.24-1.3700.1760.36Psychospiritual transcendence (Post - Test)15.04 ± 3.9415.66 ± 5.03-0.5160.6080.13Test valueb /p-0.793/0.4340.433/0.668 Cohen’s d 0.14-0.08Environmental transcendence (Pre - Test)5.82 ± 2.446.28 ± 2.46-0.7000.4870.18Environmental transcendence (Post- Test)6.86 ± 2.887.00 ± 2.60-0.1970.8450.05Test valueb /p -2.416/0.023 -1.247/0.223 Cohen’s d 0.500.23Sociocultural ease (Pre - Test)13.57 ± 1.9713.31 ± 2.270.4630.645-0.12Sociocultural ease (Post - Test)14.61 ± 1.0314.76 ± 0.83-0.6120.5430 0.16Test valueb /p -2.527/0.018 -3.524/0.001 Cohen’s d 0.380.52HDSC II (Pre - test)91.32 ± 14.5997.21 ± 16.01-1.4490.1530.38HDSC II (post - test)97.68 ± 16.4298.52 ± 15.16-0.9180.3630.24Test valueb /p -3.287/0.003 2.181/0.077 Cohen’s d 0.660.37Abbreviations: HDCS II Hemodialysis Comfort Scale Versiyon IIa Independent sample t test, b Dependent sample t testBold values indicate statistically significant results p < 0.05 Comparison of HDSC II total and subscale score averages of experimental and control groups (n = 57) Abbreviations: HDCS II Hemodialysis Comfort Scale Versiyon II a Independent sample t test, b Dependent sample t test Bold values indicate statistically significant results p < 0.05 Discussion The findings of the present study, conducted to determine the effect of stress ball use on stress, sleep quality, and comfort levels in individuals receiving hemodialysis, were discussed in line with the literature. The perceived stress levels of patients in both the experimental and control groups were above the moderate level. Perceived stress levels significantly decreased in the experimental group that used stress balls, while increasing in the control group. Similar studies indicate that stress and anxiety levels decrease in individuals receiving hemodialysis who use stress balls [29–31]. The present study yielded results consistent with those of previous research. Stress balls, as a non-pharmacological method to reduce stress and anxiety, have been reported to regulate the functioning of the nervous system, reduce the release of stress hormones, and promote relaxation and comfort. In the current study, the use of stress balls facilitated patients’ relaxation, provided comfort, and shifted their focus toward the stress ball, thereby reducing perceived stress levels. In addition to psychological factors such as relaxation and focus shifting, the stress-reducing effect of the intervention can also be explained by neurobiological mechanisms [37, 38]. This physiological process not only supports relaxation and comfort but may also help divert attention away from the source of stress. Therefore, it is considered that the use of stress balls can help patients relax, provide comfort, and reduce perceived stress levels. The study identified that individuals in both the experimental and control groups had poor sleep quality. Sleep quality improved in patients who used the stress ball in the experimental group, whereas it remained unchanged in the control group. In addition, ANCOVA, conducted to control for baseline differences in pre-test scores, revealed a statistically significant difference between the groups in adjusted post-test PSQI scores. The adjusted post-test mean score of the control group was higher than that of the experimental group, supporting the conclusion that the use of a stress ball may be an effective intervention for improving sleep quality in individuals receiving hemodialysis. Studies in the literature assessing the sleep quality of individuals receiving hemodialysis report poor sleep quality among this population [12, 16, 39]. No studies were found to examine the effects of stress ball use on the sleep quality of individuals receiving hemodialysis. This led to review studies examining the effects of other non-pharmacological methods used with individuals receiving hemodialysis on sleep quality. Massage therapy [40, 41] and progressive relaxation exercises [17, 42] improve sleep quality in individuals receiving hemodialysis. Poor sleep quality can negatively impact the ability of individuals receiving hemodialysis to perform daily activities, maintain work and social lives, and overall quality of life. Therefore, it is essential for nurses, particularly in providing care to individuals receiving hemodialysis from a holistic perspective, to assess patients’ sleep patterns and implement nursing interventions addressing identified issues. Proven, low-cost, and user-friendly non-pharmacological methods can be integrated into nursing interventions to improve patients’ sleep quality. In the present study, the use of a stress ball was expected to enhance relaxation in individuals receiving hemodialysis, thereby improving their sleep quality. Individuals in both groups exhibited a comfort level above the medium range, with the comfort level of the experimental group significantly increasing, while that of the control group remained unchanged. In addition, a significant increase in the sociocultural relaxation subscale was observed in both the experimental and control groups. A review of studies evaluating the comfort levels of individuals receiving hemodialysis indicates that their comfort levels are at a moderate level [43–45] and above moderate levels [46, 47]. Considering studies examining the effect of stress ball usage on comfort levels, Kasar et al. (2020) [30], involving 45 individuals receiving hemodialysis, found no significant effect of stress ball usage on comfort levels. Due to the absence of other studies in the literature specifically investigating the impact of stress balls on comfort levels, studies that explored the effects of other non-pharmacological methods on comfort levels were reviewed. These studies indicate that progressive relaxation exercises [48], listening to music [49], reiki [27] and back massage [50] enhance the comfort levels of individuals receiving hemodialysis. In the present study, the use of stress balls likely contributed to the relaxation of patients, which may have led to an increase in their comfort levels. Furthermore, the reduction in perceived stress levels and the improvement in sleep quality among patients using stress balls may also have contributed to an enhancement in their comfort levels. In addition, the increase in scores on the sociocultural relaxation subscale observed in both groups may be attributed to the regular nurse- patient interactions and supportive communication inherent in hemodialysis treatment. This finding highlights the importance of using active control groups in future studies to more accurately determine the true effect of the intervention. Strengths and limitations This study has several strengths and limitations that should be considered when interpreting the findings on the effects of stress ball use on stress, sleep quality, and comfort levels in individuals receiving hemodialysis. One strength is that it employed a randomized controlled trial design. Validated and reliable measurement instruments (PSS, PSQI, HDCS-II) were used, and the intervention protocol was standardized, ensuring consistent implementation across participants. However, certain limitations should be acknowledged. The relatively small sample size, the single-center setting, and the absence of an assessment of the long-term effects of stress ball use on stress, sleep quality, and comfort levels constitute the main limitations of the present study. Furthermore, the results may not be generalizable to other hemodialysis units or cultural contexts, particularly those with different nurse-to-patient ratios or patient populations with limited hand mobility. In addition, the inability to blind participants to stress ball use may have influenced self-reported outcomes through placebo effects or a tendency to respond in line with perceived researcher expectations. Nevertheless, objective measures such as the PSQI demonstrated similar trends, suggesting that the observed intervention effects were not solely attributable to participant expectations. Conclusion This study shows that the use of stress balls reduces the perceived stress levels of individuals receiving hemodialysis treatment while enhancing their sleep quality and comfort levels. Based on these findings, it is believed that the use of stress balls can positively contribute to stress, sleep quality, and comfort levels in individuals receiving hemodialysis. In this context, this easy-to-use and cost-effective method can be integrated into nursing practices. For example, stress balls could be offered to patients during the second hour of dialysis sessions, accompanied by brief training on proper use (e.g., squeezing for approximately 3 s, 10 repetitions per minute), with particular emphasis on patients presenting with higher baseline stress levels. However, there is a need for further studies to assert that the use of stress balls effectively influences stress levels, sleep quality, and comfort in individuals receiving hemodialysis. Therefore, similar studies can be conducted with different sample groups. Supplementary Information Supplementary Material 1. Acknowledgements We would like to thanks the patients who participated in the study. We would like to thank the statistics expert who made the statistics of the research. Abbreviations Chronic Kidney Disease Intention-To-Treat Perceived Stress Scale Pittsburgh Sleep Quality Index Hemodialysis Comfort Scale Version II Statistical Package for Social Sciences Authors’ contributions A.K.V and D.G.G wrote the main manuscrript. All authors reviewed the manuscript. Funding This study was not supported financial. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate To conduct the study, ethical approval was obtained from the institution’s Scientific Research and Publication Ethics Committee (Date: February 13, 2024; Decision No: 240010/29), along with institutional permission from the hospital where the research was conducted. In addition, written informed consent was obtained from the patients after they were informed about the study’s purpose. Permission to use the scales was acquired via email from the scale developers. The trial was registered on the ClinicalTrials.gov website number with NCT06835998. Consent for publication All authors have approved their consent. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement No datasets were generated or analysed during the current study.